Drug intelligence / Profile preview

Armour Thyroid

Development stage: Unknown
Lead developer: AbbVie
Administration: Oral

Overview

**Armour Thyroid** is an oral natural desiccated thyroid extract derived from porcine thyroid glands and containing both thyroxine and triiodothyronine. It is being studied by AbbVie for **primary hypothyroidism** in a randomized dose-conversion trial versus levothyroxine in patients stabilized on synthetic T4. Pharmacologically, it functions as **thyroid hormone replacement**, with T4 and T3 acting as agonists of thyroid hormone receptors to restore thyroid hormone signaling in hypothyroid patients; this is a hormone replacement product rather than a novel targeted synthetic agent.

Brand names: Armour Thyroid
Other names: desiccated thyroid extractnatural desiccated thyroidthyroidthyroid extract

Targets

THRA (Thyroid hormone receptor alpha)THRB (Thyroid hormone receptor beta)

Beyond the preview

Go deeper on Armour Thyroid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Armour Thyroid.

Explore the full profile